Department of Hematology, Faculty of Medicine, Gazi University, Beşevler, 06500 Ankara, Turkey.
Int J Hematol. 2012 Jan;95(1):95-101. doi: 10.1007/s12185-011-0980-y. Epub 2011 Dec 9.
Patients with impaired nutritional status may show increased risk of hematopoietic stem cell transplantation (HSCT)-related complications. This study was conducted to determine whether body mass index (BMI) and other body composition parameters, such as lean body mass index (LBMI) and body fat mass (BFM), are associated with early post-transplantation toxicity and mortality in allogeneic HSCT recipients. The records of 71 patients diagnosed with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), or myelodysplastic leukemia (MDS) who had undergone allogeneic HSCT with a conditioning regimen of busulfan-cyclophosphamide (Bu-Cy), between September 2003 and January 2009 at the Stem Cell Transplantation Unit of Gazi University Hospital were retrospectively evaluated. BMI was found to be negatively correlated with the NCI grade of mucositis, cardiotoxicity, emesis, and hyperglycemia, and with the number of erythrocyte transfusions. LBMI was also negatively correlated with the number of erythrocyte transfusions, cardiotoxicity, emesis, and hyperglycemia. BFM was negatively correlated with the day of neutrophil engraftment, and NCI grade of mucositis. Nutritional status did not have an impact on overall survival (OS), progression-free survival (PFS), or 100-day transplant related mortality (TRM).
营养状况受损的患者可能会增加造血干细胞移植 (HSCT) 相关并发症的风险。本研究旨在确定体重指数 (BMI) 和其他身体成分参数,如去脂体重指数 (LBMI) 和体脂肪量 (BFM),是否与异基因 HSCT 受者移植后早期毒性和死亡率相关。回顾性分析了 2003 年 9 月至 2009 年 1 月在加济大学医院干细胞移植科接受以白消安-环磷酰胺 (Bu-Cy) 为预处理方案的异基因 HSCT 的 71 例急性髓性白血病 (AML)、急性淋巴细胞白血病 (ALL)、慢性髓性白血病 (CML) 或骨髓增生异常综合征 (MDS) 患者的记录。BMI 与 NCI 级别的粘膜炎、心脏毒性、呕吐和高血糖呈负相关,与红细胞输注次数呈负相关。LBMI 也与红细胞输注次数、心脏毒性、呕吐和高血糖呈负相关。BFM 与中性粒细胞植入天数和 NCI 级别的粘膜炎呈负相关。营养状况对总生存 (OS)、无进展生存 (PFS) 或 100 天移植相关死亡率 (TRM) 没有影响。